Related Experiment Video
Updated: Apr 19, 2026
06:51
A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
30.9K
A bioengineered murine model using CD24⁺CD44⁺ pancreatic cancer stem cells for chemotherapy study
Shengqi Qin1, Yiming Deng, Jianshe Li
1Department of General Surgery, Beijing Friendship Hospital, Beijing, 100050, People's Republic of China. Department of Neurology, Beijing Tiantan Hospital, Beijing, 100050, People's Republic of China.
Biomedical Materials (Bristol, England)
|December 24, 2014
Summary
A novel pancreatic cancer model using cancer stem cells (CSC) and a scaffold effectively tested chemotherapy. The irinotecan/gemcitabine (IRIN-GEM) regimen demonstrated superior tumor regression by targeting CSC, offering a promising treatment for advanced pancreatic cancer.
Area of Science:
- Oncology
- Biomaterials Science
- Cancer Stem Cell Research
Background:
- Pancreatic cancer remains a significant health challenge with limited effective treatments.
- Conventional murine models for pancreatic cancer often exhibit high variability, hindering drug development.
- Cancer stem cells (CSCs) are implicated in tumor initiation, progression, and therapeutic resistance.
Purpose of the Study:
- To develop a reliable and reproducible murine pancreatic tumor model using defined cancer stem cells (CSCs) and an electrospun scaffold.
- To evaluate the efficacy of the irinotecan/gemcitabine (IRIN-GEM) chemotherapy regimen in this novel model.
- To elucidate the mechanism underlying the effectiveness of IRIN-GEM against pancreatic CSCs.
Main Methods:
- Development of a murine pancreatic tumor model utilizing CD24(+)CD44(+) pancreatic CSCs on a chemically defined electrospun scaffold.
- In vitro assessment of scaffold cytotoxicity and CSC apoptosis.
- In vivo evaluation of tumorigenesis acceleration and tumor formation.
- Comparative analysis of IRIN-GEM versus gemcitabine monotherapy for tumor growth inhibition and regression.
Main Results:
- The electrospun scaffold supported CSCs without inducing apoptosis, confirming its non-cytotoxic nature.
- The novel model demonstrated accelerated in vivo tumorigenesis and reduced variability compared to conventional models.
- IRIN-GEM induced significant tumor regression, whereas gemcitabine alone only arrested tumor growth.
- IRIN-GEM effectively eliminated the CD24(+)CD44(+) CSC sub-population through apoptosis.
Conclusions:
- The developed murine model using defined CSCs and a scaffold provides a reliable platform for preclinical cancer drug evaluation.
- The IRIN-GEM chemotherapy regimen shows significant promise for treating advanced pancreatic cancer by targeting CSCs.
- Targeting the CSC population is a crucial strategy for achieving effective pancreatic cancer chemotherapy.
